Werewolf Therapeutics, Inc. (HOWL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Werewolf Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.48x | -0.91x | -3.68x | -1.10x | -4.40x | -30.89x |
| P/B Ratio | 1.18x | 0.87x | 1.24x | 0.48x | 1.44x | 5.17x |
| P/S Ratio | 0.00x | 34.02x | 6.90x | 3.61x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 3.8% | 91.2% | 84.7% | 0.0% | 0.0% |
| Operating Margin | 0.0% | -3904.2% | -203.1% | -341.8% | 0.0% | 0.0% |
| Net Margin | 0.0% | -3740.8% | -187.4% | -328.1% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | -3397.6% | -162.8% | -312.8% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.62x | 7.45x | 7.14x | 5.84x | 13.56x | 17.58x |
| Quick Ratio | 1.62x | 7.45x | 7.14x | 5.84x | 13.56x | 17.58x |
| Leverage | ||||||
| Debt/Equity | 0.38x | 0.51x | 0.47x | 0.12x | 0.10x | 0.03x |
YoY = year-over-year change. Source: FMP..